Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2004
03/25/2004US20040058965 Alkanoic acid derivatives process for their production and use thereof
03/25/2004US20040058954 Antiproliferative agents; anticancer agents
03/25/2004US20040058934 Heterocyclic compounds
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058904 Antiinflammatory agents; autoimmune disease
03/25/2004US20040058903 Anticholesterol agents; cardiovascular disorders
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004CA2483771A1 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers
03/24/2004EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
03/24/2004EP1400515A1 Cyclic diamine compound having five-membered cyclic group
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1399430A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
03/24/2004EP1399421A1 Substituted imidates as pesticidal agents
03/24/2004EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors
03/24/2004EP1399419A1 New compounds useful in reflux disease
03/24/2004EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
03/24/2004EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/24/2004EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004CN1484643A Hetaryl substituted homotetramic and homotetramic acids and the use thereof as pesticides
03/24/2004CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/24/2004CN1142923C 12,13-modified epothilone derivatives
03/24/2004CN1142912C Amide derivs, useful as inhibitors for production of cytokines
03/24/2004CN1142909C Indole derivatives with antiviral activity
03/24/2004CN1142778C Use of thiazolium compounds for preventing and preventing the formation of advanced glycosylation endproducts
03/23/2004US6710182 Reacting 5-hydroxymethylthiazole-diazonium salt with hydrogen halide or mineral acid; chlorination, desalting, dehydroxylation
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710063 Activators of PPAR delta
03/23/2004US6710062 Fungicidal compound having a cyanomethylene group bonded to the 2- position on the thiazolidine ring
03/23/2004US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii.
03/23/2004US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole
03/23/2004US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
03/18/2004WO2004022549A1 Process for producing 4-methyl-1,3-thiazol-2-ylsulfonyl halide
03/18/2004WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers
03/18/2004WO2004022526A1 Cathepsin cysteine protease inhibitors
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/18/2004WO2004021997A2 Inhibitors of fungal invasion
03/18/2004WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction
03/18/2004WO2003075858A3 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054189 Purification in acidity aqueous solution; chemical intermediates; isomer mixtures
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity
03/18/2004US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto
03/18/2004US20040053932 Peptide deformylase inhibtors
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040052914 Flavouring a foodstuff by incorporating an effective amount of at least one compound of the formula r1-s-r2 in which r1 and r2 represent a specific atom or group
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2497827A1 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
03/18/2004CA2495939A1 Cathepsin cysteine protease inhibitors
03/18/2004CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers
03/17/2004EP1398030A2 Dipeptidyl peptidase IV effectors
03/17/2004EP1398024A2 Uses for thyroid hormone compounds
03/17/2004EP1397678A1 Luciferin hydrazides
03/17/2004EP1397488A1 Novel compounds for chemiluminescense procedures
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
03/17/2004EP1185520B1 Method for the production of thiazolidin
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
03/17/2004EP1097148B1 Polymorph of ritonavir
03/17/2004EP1091946B1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
03/17/2004CN1482907A Compounds having fungicidal activity and processes to make and use same
03/17/2004CN1482120A Process for preparing S,Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound
03/17/2004CN1142152C Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
03/16/2004US6706835 Adhesion promoters; high strength bonding to metals; semiconductors, integrated circuits
03/16/2004US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent
03/16/2004US6706746 Thiadiazolidin-2,4-dione compound
03/16/2004US6706744 Hypoglycemic agents; antidiabetic agents
03/16/2004US6706743 β3 adrenergic receptor agonists and uses thereof
03/16/2004US6706742 Alpha-amino-acid compounds
03/16/2004US6706729 A method for dissociating a metal ion from a zinc finger-containing protein; inhibiting virus
03/16/2004US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases
03/11/2004WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
03/11/2004WO2004020420A1 Novel 2-arylthiazole compounds as pparalpha and ppargama agonists
03/11/2004WO2004020393A1 Dibenzylamine compound and medicinal use thereof
03/11/2004WO2004019938A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
03/11/2004WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004WO2002075318A3 Neurofibrillary labels
03/11/2004US20040049051 Produced by fermenting DSM 6773
03/11/2004US20040049040 Pohtochromic material
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048858 Chalcone derivatives and their use to treat diseases
03/11/2004US20040048774 Inhibitors of IMPDH enzyme
03/11/2004CA2495917A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
03/10/2004EP1395572A1 Process for preparing a thiazole ppar-ligand and polymorphs thereof
03/10/2004EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections
03/10/2004EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors
03/10/2004EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
03/10/2004EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
03/10/2004EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease
03/10/2004CN1481382A Isoindolin-1-one glucokinase activators
03/10/2004CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same